Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma

Overview of attention for article published in American Journal of Clinical Oncology: Cancer Clinical Trials, December 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#39 of 1,758)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 27 X posts from 23 X users, with an upper bound of 26,093 followers.

RT @MSK_RadOnc: The @RadiumSociety multiD GI expert panel developed these Appropriate Use Criteria evaluating the evidence regarding neoadj…

RT @MSK_RadOnc: The @RadiumSociety multiD GI expert panel developed these Appropriate Use Criteria evaluating the evidence regarding neoadj…

RT @MSK_RadOnc: The @RadiumSociety multiD GI expert panel developed these Appropriate Use Criteria evaluating the evidence regarding neoadj…

RT @MSK_RadOnc: The @RadiumSociety multiD GI expert panel developed these Appropriate Use Criteria evaluating the evidence regarding neoadj…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 23 additional X posts.